Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Health Secretary Opens New Cancer Hospital
Thousands of patients in Cumbria are set to benefit from state-of-the-art cancer diagnosis and treatment […]
DocSpace, Houston-Based Digital Health Startup, Raises $1.2 Million to Help Clinicians Build and Launch Independent Practices
DocSpace, a digital health commerce platform that helps clinicians start, manage, and grow tech-enabled private […]
First Monoclonal Antibody Treatment for COVID-19 Approved for Use in the UK
Following on from a thorough review of the evidence carried out by the MHRA, and […]
MiSalud Raises $5M to Launch a Personalized Digital Health and Wellness Platform for the Underserved US Hispanic Community
MiSalud Inc. announced raising $5M and launching the beta version of their digital health platform. […]
New Collaboration Between NICE and AHSN will Help Embed Innovations into the Healthcare System for the Benefit of Patients
NICE and the Academic Health Science Network (AHSN) have today (4 August) announced a two-year […]
Verizon Business Streamlines Patient Care Experience with Advancements to BlueJeans Telehealth
Verizon Business today announced that BlueJeans Telehealth, a purpose-built, HIPAA-ready virtual care solution to help […]
CUNY SPH and NYC Health Department Awarded $3.3 Million to Study New HIV Intervention
The National Institute of Mental Health (NIMH) has awarded the CUNY Graduate School of Public […]
Optimize Health Expands Leadership Team With Three New Executive Hires
Optimize Health, a leader in Remote Patient Monitoring (RPM), today announced it has expanded its […]
DePuy Synthes Introduces the INHANCE ™ Shoulder System, a First-to-Market, Fully Integrated Shoulder Arthroplasty System
Today, The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes, The Orthopaedics Company […]
Roche Receives FDA Approval for First Companion Diagnostic to Identify dMMR Solid Tumour Patients Eligible for Anti-PD-1 Immunotherapy
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more